Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 4, 2002, Pages 354-357

  Kim, Kihyun ^a   Nam, Eunmi ^a   Lee, Nam Soo ^a   Lee, Hye Ran ^a   Lee, Jee Yun ^a   Lee, Hyo Rak ^a   Park, Se Hoon ^a   Oh, Sung Yong ^a   Kim, Ji Hyang ^a   Song, Seo Young ^a   Park, Joon Oh ^a   Kim, Won Seog ^a   Jung, Chul Won ^a   Im, Young Hyuk ^a   Lee, Mark H ^a   Lee, Woo Yong ^a   Chun, Hokyung ^a   Park, Chan H ^a   Park, Keunchil ^a   Kang, Won Ki ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Colorectal cancer; Combination chemotherapy; Oxaliplatin; UFT

Indexed keywords

OXALIPLATIN; UFT;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NAUSEA; NEUTROPENIA; PERITONEUM METASTASIS; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; STOMATITIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; SURVIVAL ANALYSIS; TEGAFUR; URACIL;

EID: 0036340246     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200208000-00007     Document Type: Article

References (30)

1. Cancer of the colon
2. Annual report of the central cancer registry in Korea - 1998 (based on registered data from 124 hospitals)
3. Therapeutic options for the treatment of colorectal cancer following 5-fluorouracil failure
4. Protracted venous infusion of 5-fluorouracil as a salvage chemotherapy in colorectal cancer
5. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
6. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
7. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
8. Oxaliplatin. Mechanism of action and antineoplastic activity
9. Pharmacokinetics and safety profile of oxaloplatin
10. Clinical efficacy of oxaliplatin monotherapy: Phase II trials in advanced colorectal cancer
11. Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
12. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
13. Oral fluoropyrimidines in colorectal cancer
14. Uracil-ftorafur. An oral fluoropyrimidine active in colorectal cancer
15. Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal cancer
16. Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice
17. Reporting results of cancer treatment
18. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in term of response rate
19. Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
20. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen
21. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOL-FOX6)
22. Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program
23. Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study
24. A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: Evolution of a regimen
25. Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil
26. Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study
27. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
28. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorou-racil-leucovorin as first-line treatment of metastatic colorectal cancer
29. Oral fluoropyrimidines: A close look at their toxicities
30. Oral fluoropyrimidine-based combination therapy in gastrointestinal cancer